DUBLIN--(BUSINESS WIRE)--The "Cholesterol Lowering Drug Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.
The report on cholesterol lowering drug market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global cholesterol lowering drug market over the period of 2016 to 2024.
Market Dynamics
Drivers
- Growth in the Intake of Saturated & Trans Fat and Tobacco Smoking
- Growing Occurrences of High-density Lipoproteins (HDL) Cholesterol & Cardiac Diseases
Restraints
- Risks of Side-effects
Opportunities
- Growing Spending Capacity on Healthcare
- Increasing Aging Population
Company Profiles
- AstraZeneca
- Amgen
- Merck and Co.
- Daiichi Sankyo
- Bristol-Myers Squibb
- Pfizer
- Kowa Company Ltd.
- AbbVie
- Sanofi
- Novartis
Key Topics Covered
1. Preface
2. Executive Summary
3. Global Cholesterol Lowering Drug Market Overview
4. Cholesterol Lowering Drug Market Macro Indicator Analysis
5. Global Cholesterol Lowering Drug Market by Class of Drugs
6. Global Cholesterol Lowering Drug Market by Region
7. Company Profiles and Competitive Landscape
For more information about this report visit https://www.researchandmarkets.com/research/rlqgc3/global?w=4
